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Natural Killer cells are a subset of cytotoxic lymphocytes that are important in host defense
against infections and transformed cells. They exert this function through recognition of
target cells by cell surface receptors, which triggers a signaling program that results in a
re-orientation of the microtubule organizing center and secretory lysosomes toward the
target cell. Upon movement of secretory lysosomes to the plasma membrane and sub-
sequent fusion, toxic proteins are released by secretory lysosomes in the immunological
synapse which then enter and kill the target cell. In this minireview we highlight recent
progress in our knowledge of late steps in this specialized secretion pathway and address
important open questions.
Keywords: lytic granules, secretory lysosomes, maturation, endosomes, degranulation
Natural Killer (NK) cells and cytotoxic T lymphocytes (CTL)
are essential effectors of innate and adaptive immunity against
infected or nascent cancer cells (1). The cytotoxic process is ini-
tiated by recognition of target cells via immune receptors and
accessory plasma membrane proteins (2). CTL are activated via
the T cell receptor (TCR) that interacts with MHC class I mole-
cules and cognate antigenic peptides derived from target cells. NK
cytotoxicity occurs via ligation of activating receptors and is kept
in check by recognition of self MHC class I molecules. Cytotoxic
lymphocytes use two non-redundant pathways to execute their
effector functions. The first of which involves the interaction of
Fas ligand on CTL and NK cells with Fas receptor on the target
cell, which causes receptor oligomerization and apoptosis of the
target cell (3). The second pathway also known as the lytic granule
pathway represents a rapid and efficient exocytic transport route
of vesicular structures containing the lytic molecules perforin and
granzymes and is the focus of this minireview.
The lytic granule pathway involves the vectorial and polarized
trafficking of the granules toward the immunological synapse
and the re-organization of the microtubule organizing center
toward the target cell and subsequent release of cytotoxic pro-
teins. Besides the cytotoxic proteins, the granules also contain
lysosomal enzymes, an acidic proteoglycan core, and lysosome-
associated membrane proteins. Since this content is released by
outside in signaling, lytic granules represent a hybrid organelle
with shared properties of lysosomes and secretory granules and
are therefore also called secretory lysosomes or lysosome related
organelles (4, 5).
An essential driver for the development of our understanding
of the lytic pathway was the presentation of patients with Famil-
ial Hemophagocytic Lymphohistiocytosis (FHL), whose cytotoxic
lymphocytes fail to kill target cells. As a consequence of which
patients suffer from uncontrolled and massive lymphocyte and
macrophage proliferation. A group of genes has been discov-
ered in which mutations causes strongly impaired lytic capacity.
These include RAB27A (Griscelli syndrome type 2, GS2), UNC13D
(FHL3), STX11 (FHL4), and STX-BP2 (FHL5), which encode pro-
teins of conserved families that regulate membrane trafficking (4).
It is thought that the related disease phenotype of the cytotoxic
lymphocytes, reflects the functional organization of the wild type
forms of these proteins in a network that cooperatively regulates
the degranulation pathway. Although this is a widely held belief,
our understanding of the molecular mechanisms coupling their
function in regulating the degranulation pathway and how they
are controlled by upstream signaling is limited.
Even though NK cells and CTL functions belong to distinct
arms of immunity, mutations in genes causing FHL produce
dramatic yet remarkably related cytoarchitectural and immun-
odeficiency phenotypes. In addition, primary CTL and NK cell
responses reveal similar molecular requirements (6, 7). Collec-
tively this supports the notion of a common principle for granule
exocytosis in cytotoxic lymphocytes on which cell-type specific
layers of signaling are superimposed. We therefore will not distin-
guish between the lytic granule pathway in CTL and NK in our
discussion.
MATURATION OF SECRETORY LYSOSOMES
Careful electronmicroscopy studies in CTL, mast cells, and
melanocytes revealed a heterogenous appearance of secretory
lysosomes in terms of cytoplasmic localization, size, and elec-
tron dense luminal matrix (8–10). Kinetic tracer uptake exper-
iments and antibody labeling on ultrathin sections suggested
the presence of three or more classes of secretory lysosomes,
that likely represent different stages in the formation of mature
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secretory lysosomes. Secretory lysosomes are formed from pre-
cursor organelles through a series of distinct membrane transport
steps that continuously deliver house-keeping content and specific
effector molecules from endosomes, the trans Golgi network, and
the cytoplasm (11). How the pathways between them and with
other granules are regulated is only recently being explored (12–
15). An early stage in the formation of secretory lysosomes involves
the merger of recycling endosomes containing rab11 and munc13-
4 with late endosomes characterized by the presence of rab27a
and rab7, to a so called exocytic endosome (Figure 1). The coales-
cence of the two endocytic structures might serve to bring exocytic
traffic regulatory proteins that are needed at later stages of the
secretory lysosome release. Since rab11 does not bind munc13-4
(13), other small GTPases could provide a link between munc13-4
and the endosomal system. Rab15 an endosome-localized rab (16)
might take on this task as it binds to munc13-4 and coregulates
with rab27 the exocytosis of von Willebrandt factor from Weibel–
Palade bodies (17), the secretory lysosomes of endothelial cells.
FIGURE 1 | Maturation and fusion. Pathways and proteins regulating various aspects of the maturation and fusion of secretory lysosomes (see text for
details). PM denotes plasma membrane, IS immunological synapse.
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The tetrameric adaptor complex AP-1 and kinesin KIF13A rep-
resent two other membrane traffic regulators through recycling
endosomes that have been implicated in the function of secre-
tory lysosomes (18). A complex of AP-1 and KIF13A is thought to
define a recycling endosomal domain partially overlapping with
rab11 (18) that could facilitate cargo sorting. The AP-1*KIF13A
complex positions endosomes close to secretory lysosomes in the
cell periphery thereby facilitating interorganellar connections.
TETHERING SECRETORY LYSOSOMES AT THE PLASMA
MEMBRANE
A second step in secretory lysosome maturation occurs when
the cytotoxic lymphocyte engages itself in an interaction with a
target cell during which the exocytic endosomes and associated
exocytic machinery move to the immunological synapse in par-
allel with organelles containing LAMPs, perforin, and granzymes.
At least two scenarios are compatible with the available data for
the next stage in the secretory lysosome maturation pathway. The
two organelles may fuse with each other to generate a structure
with lytic and exocytic potential at the immunological synapse.
Alternatively, tethering of the exocytic endosome equipped with
munc13-4, rab27, and rab11, to the lytic precursor organelle with
perforin and granzyme (without actual fusion) is already suf-
ficient to assemble and concentrate the protein machinery for
efficient docking and fusion at the plasma membrane (Figure 1).
Enhanced tethering of secretory lysosomes that are paired with
TCR-containing endosomes has been observed at the immuno-
logical synapse of CTL. In effect tethering prolongs the dwelling
time of the organelle at the immunological synapse which facili-
tates the subsequent fusion step with the plasma membrane, and
release of lytic content (19). In support of this notion, we uncov-
ered a second role for munc13-4 in tethering secretory lysosomes at
the cell surface that is regulated independently from the upstream
function of munc13-4 on recycling endosomes. Total Internal
Reflection Fluorescence microscopy of cells expressing munc13-4
point mutants defective in rab27a-binding revealed that secre-
tory lysosomes are severely impaired in the characteristic stalling
behavior seen upon initiation of immune receptor signaling, show-
ing that a complex between munc13-4 and rab27a is required for
the tethering role of munc13-4 at the plasma membrane (12).
In neutrophils, munc13-4 was also found to limit mobilization
of rab27a positive granules after lipopolysaccharide stimulation
and to restrict them at the plasma membrane (20), suggesting a
more general role of the rab27*munc13-4 complex in immune
cells.
Molecular insight into the question as to how munc13-4 could
serve as a tethering molecule derived from computational struc-
ture predictions which revealed very weak homology between the
MUN domain and subunits of intracellular membrane tether-
ing complexes (21). The MUN domain is the central region of
munc13-4 that is interspaced between the C2B and C2C domains
(Figure 2). It contains two conserved munc homology domain
sequences (22) that constitute an autonomously folding MUN
domain. The MUN domain is conserved in all munc13’s and
related proteins and is principally involved in the priming func-
tion. The subsequent structure of the MUN domain (23) revealed
that it folds into a two-stacked helical bundle, characteristic for the
FIGURE 2 | Domain architecture of munc13-4. The C2B domain was
modeled on the munc13-2 C2B domain structure (26). Note the
rab27-binding domain at the junction between C2B and MUN domain.
exocyst subunit sec6 and other members of the CATCHR family
(complex associated with tethering containing helical rods) of
tethering factors. Additional subunits of the oligomeric exocyst,
GARP, COG, and Dsl1 tethering complex complexes (24) also
fold in this structure as do the cargo binding sites of yeast type
V myosins (25). Another common denominator in these com-
plexes is their propensity to bind traffic regulators like rho and rab
GTPases, SNAREs, and phospholipids.
We recently characterized the requirements for rab27-binding
to munc13-4, and mapped the rab27-binding site to a short
sequence just at the junction of the MUN and C2B domains
(12) (Figure 2). Since the munc13 C2B domain engages in Ca2+-
dependent PI(4,5)P2 binding and the C2C domain might constitu-
tively bind membranes, munc13-4 could bridge two membranes
via this multiplicity of interactions. CTL and NK cells express
two other rab27a effectors, slp1 and slp2-a. Both are non-essential
for secretory lysosome release, but they could assist in tethering
since their C2 domains are important for membrane binding and
they focus tightly at the immunological synapse (27, 28). Since
the MUN domain of neuronal munc13 interacts with syntaxin-1
(26), we anticipate that munc13-4 will also bind to a (yet to be
identified) syntaxin. In that vein munc13-4 mediated tethering
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could control specificity in SNARE reactions needed for secretory
lysosome fusion.
In contrast to molecules on the secretory lysosome that facilitate
tethering and docking at the immunological synapse, the molecu-
lar cue(s) on the partnering inner leaflet of the plasma membrane
have not yet been defined. Given the analogies between cytoki-
nesis, polarized exocytosis, and degranulation (29) we speculate
that exocyst complex subunits could play a role in this pathway.
Several lines of evidence are in accordance with this notion. The
exocyst subunit sec15 binds directly to rab27 (30), while the cap-
ture of secretory granules depends on the rab27a effector MyRIP
that interacts directly with exocyst subunits sec6 and sec8 (31,
32). Finally, munc13-4 localizes via its C2B domain to PI(4,5)P2-
enriched regions on the plasma membrane (33), while PI(4,5)P2
is also key to localizing exocyst subunits sec3 (34) and exo70
(35). Thus molecules important for polarized secretion in other
cell types, are implicated in the degranulation pathway through
putative interactions with rab27 and munc13-4.
FUSION OF SECRETORY LYSOSOMES WITH THE PLASMA
MEMBRANE
Tethering of munc13-4, rab27, and rab11 structures with LAMP
containing organelles can be considered as a pre-requisite for late
endosome-lysosome fusion. In CTL and macrophages this het-
erotypic fusion event has been shown to involve the Qb SNARE
vti1b, which is required for release of secretory lysosome content
(19, 36, 37) (Figure 1). Interestingly, vti1b interacts with the Qa
SNARE syntaxin-11 in macrophages, where silencing of syntaxin-
11 causes formation of enlarged late endosomes and inhibition of
late endosome-lysosome fusion. In accordance with this function,
syntaxin-11 associates predominantly with compartments of the
late endosome-lysosome system in a variety of immune cells. In
NK cells it colocalizes with CD-MPR in late endosomes, relocates
to the immunological synapse, but is not found on lytic granules
(38). In CTL syntaxin-11 localizes to an organelle close to but
not on lytic granules (39), while it is found mainly in LAMP-1
and LBPA containing late endosomes in macrophages (37). Loss
of syntaxin-11 function causes FHL4 in man (40, 41) and hemo-
phagocytosis in mice (42–44). NK cells and CTL of FHL4 patients
normally polarize their secretory lysosomes to the immunological
synapse, but fail to release their content. This phenotype is very
similar to munc13-4 deficiency in FHL3 patients and strongly
argues that syntaxin-11 acts in the same pathway as munc13-4.
Unlike for Griscelli type 2 and FHL3 patients, ultrastructural data
are not yet available for cytotoxic lymphocytes of FHL4 patients
or the recently established syntaxin-11 knock-out mice (42–44).
Information on such features as size, position, content, num-
ber, etc., of endosomal structures and secretory lysosomes will
be required for the evaluation at what stage the lytic pathway is
blocked and where syntaxin-11 function is localized with respect
of rab27a and munc13-4 activities.
In hemopoietic cells, syntaxin-11 interacts munc18-2 (45, 46),
a member of the small family of SM proteins that regulate the
activity of SNARE proteins for membrane fusion in time and in
space (47). The localization of munc18-2 has been addressed in
mast cells where it is associated with late endocytic organelles,
just beneath the plasma membrane (48). Mutations in munc18-2
cause FHL5 and also reduce the amount of its partner syntaxin-
11, suggesting that munc18-2 acts as a chaperone that stabilizes
syntaxin-11 (45, 46). Initially, inactivating munc18-2 mutations
appeared to affect degranulation in CTL, NK cells, and neutrophils
(49). More recent observations however show that patient muta-
tions of munc18-2 do not only affect cytotoxic lymphocytes but
also cause changes in the intestinal and renal epithelium result-
ing in severe diarrhea and renal proximal tubular dysfunction
(50). The fact that additional tissues are affected in FHL5, likely
reflects the more ubiquitous expression of munc18-2 compared
to munc13-4, and syntaxin-11. Many of the proteins that are
described above, act upstream of the final fusion event of secre-
tory lysosomes with the plasma membrane. The implication is that
the secretory lysosome pathway might interface with more general
fusogenic machinery at or close to the final step. Recent observa-
tions of Rettig’s lab support this idea and suggest that munc13-1
(51) and synaptobrevin 2 (52), two mediators of neuronal secre-
tion, act at the final stage of secretory lysosome exocytosis. The
daunting challenge now is to piece together which of the SNAREs
and associated proteins cooperate in the final stage to fuse the
secretory lysosomes with the plasma membrane.
A breakthrough in our understanding of munc13 and munc18
function came from in vitro reconstitution assays. Rizo’s lab
recently developed an in vitro liposome fusion assay in which
they could show for the first time a dependency of fusion on
munc18 and munc13 (53). Although this was accomplished in
combination with SNAREs involved in synaptic vesicle fusion, it
will likely provide a general explanation for the role of munc13
and munc18 proteins in membrane fusion. Ma et al. discovered
that the closed form of syntaxin is clamped in a tight complex with
munc18 and cannot bind other SNAREs. Munc13 can extract syn-
taxin through a interaction of the MUN domain with syntaxin
and possibly munc18, thereby catalyzing the formation of the full
syntaxin-SNAP-25-synaptobrevin complex and fusion (26, 53).
COUPLING FUSION OF SECRETORY LYSOSOMES WITH
ENDOCYTIC RETRIEVAL
The trafficking proteins that regulate degranulation of secre-
tory lysosomes are long lived. After exocytic release of content,
these are in principle available for re-utiliatization in a next
encounter with a target cell. A seminal paper from Eric Long’s
lab showed that lytic granules of NK cells undergo both complete
and incomplete fusion with the plasma membrane, and suggests
that incomplete fusion may promote efficient recycling of lytic
granule membrane and proteins (54). SNAREs involved in fusion
with the plasma membrane are returned by retrograde endocytic
transport (55, 56).
It is less well understood how cytoplasmic proteins like rab27
and munc13-4 are retrieved. After fusion they can either undergo
two fates, one of which involves dissociation and return through
the cytoplasm via non-vesicular transport. Alternatively they may
diffuse out in the plasma membrane or remain trapped in the
vicinity of the fusion site and be efficiently re-internalized. Fluores-
cence recovery after photobleaching experiments with munc13-4
and rab27a showed that rab27a is relatively stably associated with
membranes (57) and predominantly in the GTP bond form (58).
The turnover of munc13-4 on secretory lysosome membrane is
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also relatively slow and decreased ∼twofold after immune recep-
tor signaling in rat basophil leukemia cells (59), suggesting that
munc13-4 might be retrieved by coupling degranulation with
endocytic re-uptake. In accord with this notion, Galandrini et al.
recently found that munc13-4 was recycled back from PI(4,5)P2-
enriched domains at the immunological synapse by AP-2 depen-
dent endocytosis (33). The mechanism via which this occurs is
remarkably similar to synaptic vesicle protein retrieval in presy-
naptic neurons. CD16 stimulation of human NK cells causes tran-
sient activation of Arf6 (60) which is essential for the recruitment
of PIP5K-alpha and PIP5K-gamma to the plasma membrane, the
formation of PI(4,5)P2 pools and secretion of secretory lysosomes
(61). Upon fusion, granule membrane delivers munc13-4 to the
PI(4,5)P2 pool generated by PIP5K-gamma (33). Presumably the
association of munc13-4 depends on the C2B domain that has the
ability to bind PI(4,5)P2 (62), which in turn serves as a recruitment
hub for proteins regulating clathrin coated pit formation (63).
Subsequent sorting processes in the endosomal system might then
control delivery of re-internalized munc13-4 to its steady state
localization in recycling endosomes (12, 13, 64).
POSTTRANSLATIONAL MODIFICATIONS OF TRAFFICKING
PROTEINS REGULATING DEGRANULATION
A central question is how the signals generated by cross-linking
surface receptors with the corresponding ligands on target cells
are transduced to the proteins that regulate transport and fusion
of secretory lysosomes and how this modulates their function.
SNAREs and their partners, and rabs play an essential role in
degranulation, yet the mechanisms that determine the spatiotem-
poral control of their assembly in complexes for transport and
fusion are incompletely understood. As protein kinases serve crit-
ical roles in reversible regulation of membrane transport (65), it
is expected that phosphorylation of traffic proteins may modu-
late degranulation. In secretory lysosome exocytosis in mast cells,
cross-linking of the high-affinity FcepsilonRI receptor leads to
phosphorylation of SNAP-23 by IkappaB kinase 2, through a
upstream PKC signaling pathway that is conserved in lymphocytes
(66). Phosphorylation of SNAP-23 is essential for degranulation
as ectopic expression of phospho-mimetic SNAP-23 mutant par-
tially rescued the impaired IgE-mediated degranulation in Ikap-
paB kinase 2-deficient mast cells (67, 68). Signaling cascades in
platelets also cause phosphorylation of SNAP-23, which occurs on
Ser95 and is a positive regulator of SNAP-23 dependent mem-
brane fusion in vitro and platelet release in vivo (69). The gain in
function of phosphorylated SNAP-23 correlates with its propen-
sity to increase SNARE complex formation with syntaxin-11 and
the R-SNARE VAMP8 that is critical for lytic granule exocytosis
and cytotoxicity (36). Even though not yet shown in secretory lyso-
some release in immune cells, munc18-2 becomes phosphorylated
during stimulatory conditions for regulated secretion in epithelial
cells. As for SNAP-23, phosphorylation of munc18-2 enhances the
assembly of a membrane fusion complex which serves as posi-
tive regulatory mechanism for fusion (70). Given the wide spread
expression of munc18-2 (71), we anticipate that threonine/serine
phosphorylation of munc18-2 and SNAP-23 has a general aug-
menting role in membrane fusion underlying secretory lysosome
release (71).
PERSPECTIVE
The polarized secretion of lytic granule content in immune cells
involves integration of major cytoarchitectural changes with pre-
cisely timed vesicular transport to the immunological synapse.
Many proteins are known now that play a role in this traffic route
and are important in degranulation. A major question is to under-
stand how the signals that are initially generated upon encounter-
ing a target cell, control the proteins involved in membrane fission
and fusion processes of this pathway. It is essentially unknown
for instance if guanine nucleotide exchange factors (GEFs) and
GTPase activating proteins (GAPs) for rab27a, and thereby the
activity of the small GTPase are controlled upon signaling. This
information could contribute insight in the order with which dif-
ferent rab27a effectors are recruited within a cell. We also need to
improve our understanding where the proteins that control mem-
brane traffic during degranulation are localized. Progress on this
question will come from the application of powerful new imaging
technologies that are increasingly being employed in immuno-
logical research. Ultimately such information will be crucial to
annotate which step is controlled by which protein and how the
network of traffic regulators cooperates in degranulation.
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